Diamond Ranch Foods (PLPL) 1.0400 $PLPL
Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts
Marketwire - Fri Mar 28, 8:01AM CDT
Last month Plandai Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare(TM) cannabis extract in medical and pharmaceutical marijuana applications. Plandai will produce the new Diego Pellicer Gold(TM) extracts in both capsules and cannabis oil (for vapor use) in Pheroid(TM) and non-Pheroid(TM) versions to appeal to the broadest range of medicinal consumers.
Plandai Biotechnology's Human Clinical Trials Offer Significant Proof of Concept
Marketwire - Wed Mar 26, 8:04AM CDT
What may have been lost in Plandai Biotechnology's (OTCQB: PLPL) recently reported results from its human clinical trial to test the anti-aging properties of Phytofare(TM), is that the "statistically significant" results are themselves extremely significant to the future of the company. First and foremost, the results delivered in this human trial using Plandai's Phytofare(TM) Catechin Complex show "proof of concept," and for investors, that proof should turn out to be no small thing when it comes to the future success of this company.
Plandai Biotechnology Reports Positive Human Clinical Trial Results on New Topical Cream
ACCESSWIRE - Mon Mar 24, 8:27AM CDT
Plandai Biotechnology Inc.'s (OTCQB: PLPL), a company that develops heath products from cannabis plant extracts, reported favorable results from a recent human clinical trial involving a topical preparation of its Phytofare(TM) Catechin Complex.
Plandai Biotechnology, Inc. Submits Request to South African Legislature to Permit Cannabis Research
Marketwire - Mon Mar 24, 8:02AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced the submission of a request for ministerial dispensation to the Secretary of Parliament of South Africa to permit cannabis research in South Africa for medicinal purposes. Dr. Mario Oriani-Ambrosini, a South African legislator battling terminal cancer, recently introduced legislation to permit medical marijuana research and usage that has generated a groundswell of popular support and led to the formation of The Cancer Treatment Campaign.
Plandai Biotechnology, Inc. Announces Favorable Results for Human Clinical Trial
Marketwire - Thu Mar 20, 8:35AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced favorable results from a recent human clinical trial involving a topical preparation of its Phytofare(TM) Catechin Complex. The study, which was undertaken by Prof. Banie Boneschans, North West University in Potchefstroom, South Africa, one of the leading research universities on the continent, was a double-blind study that tested the anti-aging properties of Phytofare. Specifically, the trial tested surface parameters (scaling and roughness), skin hydration, and skin elasticity.
Plandai Biotechnology, Inc. Completes Stage 1 of Senteeko Phytofare Factory, Readies for Production
Marketwire - Tue Mar 18, 9:38AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it has completed and successfully tested Stage 1 of its state-of-the-art production facility on the Senteeko Tea Estate in South Africa. Video of the test is available on the company's website at www.plandaibiotech.com. Once fully commissioned, the factory will produce the company's proprietary Phytofare(TM) Catechin Complex, which is a highly bioavailable green tea extract that will be marketed to nutraceutical companies as an ingredient across a broad spectrum of health and wellness products.
Plandai Biotechnology Assumes Role in Legalizing Medical Marijuana in South Africa
Marketwire - Tue Mar 11, 5:01AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it will assume a role in helping to craft legislation that is expected to result in the eventual legalization of marijuana for medical purposes in South Africa. Plandai has retained the law firm Werksmans Attorneys, (LEX Africa) Sandton, South Africa, which includes health law as one of its specialties, to draft and file the company's comments on a recently introduced legislative bill that if passed, would effectively legalize medical marijuana in that country and pave the way for expanded research.
Plandai Biotechnology buys remaining minority interest in Dunn Roman
M2 - Mon Mar 10, 8:02AM CDT
US-based plant extracts company Plandai Biotechnology (OTCQB
LPL) revealed on Friday the completion of the acquisition of another 18% ownership interest in Dunn Roman Holdings Africa (Pty).
Plandai Biotechnology Announces Acquisition of Minority Holders' Interest in South African Subsidiaries
Marketwire - Fri Mar 07, 11:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has acquired an additional eighteen percent (18%) ownership interest in Dunn Roman Holdings Africa (Pty) Ltd, the South African holding and management company that operates the Senteeko Tea Estate and the Phytofare(TM) production facility. With this acquisition, Plandai now owns 100% of Dunn Roman.
Legalizing Medical Marijuana Gaining More Momentum in Mid-Term Election Year
Marketwire - Thu Mar 06, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) is one of a handful of publicly traded companies that are eagerly anticipating the legalization of medical marijuana nationwide. Currently the drug is legal medicinally in 20 states and Washington, D.C., but in this election year, that number is likely to grow. In each national election year, the frenzy begins again and with it, a growing momentum that has the U.S. drawing closer to a nationwide acceptance.
Plandai Biotechnology: A Natural Fit Into the Marijuana Industry
Marketwire - Mon Mar 03, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) has a strong executive team in place, a well thought out business plan, and now it's time for the company to make its products the star. These products include Plandai's Phytofare(TM) botanical extracts such as its Green Tea Catechin Complex and the Limonoid Glycoside Complex, as well as a line of Diego Pellicer(R) medical cannabis products. It is the latter could make the company a leader in the marijuana industry.
Future of Plandai Biotechnology's Products in Good Hands With Former Microsoft Executive Heading Up Global Marketing
Marketwire - Tue Feb 25, 8:00AM CST
Today Plandai Biotechnology (OTCQB: PLPL) named former Microsoft executive Jamen Shively as the company's Vice President of Global Marketing. Shively has an extensive and impressive resume in the world of business, and the company is confident he can deliver Plandai's products on the world stage. According to Plandai, Shively will be responsible for building brand awareness and marketing strategy for all of the company's operations. Needless to say, they found just the right man for the future of their products.
Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing
Marketwire - Thu Feb 20, 8:03AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Plandai, has been named as Vice President of Global Marketing.
Recent Marijuana News From Washington, D.C., Pivotal to Plandai Biotechnology's Success in the Industry
Marketwire - Wed Feb 19, 8:03AM CST
Plandai Biotechnology (OTCQB: PLPL) executives are certainly in favor of what 18 legislators are trying to accomplish with their letter to President Obama asking him to reclassify marijuana. They're likely equally as elated with news from the Administration last Friday that paves the way for legal banking between legitimate marijuana businesses and U.S. banks.
Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts
Marketwire - Fri Mar 28, 8:01AM CDT
Last month Plandai Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare(TM) cannabis extract in medical and pharmaceutical marijuana applications. Plandai will produce the new Diego Pellicer Gold(TM) extracts in both capsules and cannabis oil (for vapor use) in Pheroid(TM) and non-Pheroid(TM) versions to appeal to the broadest range of medicinal consumers.
Plandai Biotechnology's Human Clinical Trials Offer Significant Proof of Concept
Marketwire - Wed Mar 26, 8:04AM CDT
What may have been lost in Plandai Biotechnology's (OTCQB: PLPL) recently reported results from its human clinical trial to test the anti-aging properties of Phytofare(TM), is that the "statistically significant" results are themselves extremely significant to the future of the company. First and foremost, the results delivered in this human trial using Plandai's Phytofare(TM) Catechin Complex show "proof of concept," and for investors, that proof should turn out to be no small thing when it comes to the future success of this company.
Plandai Biotechnology Reports Positive Human Clinical Trial Results on New Topical Cream
ACCESSWIRE - Mon Mar 24, 8:27AM CDT
Plandai Biotechnology Inc.'s (OTCQB: PLPL), a company that develops heath products from cannabis plant extracts, reported favorable results from a recent human clinical trial involving a topical preparation of its Phytofare(TM) Catechin Complex.
Plandai Biotechnology, Inc. Submits Request to South African Legislature to Permit Cannabis Research
Marketwire - Mon Mar 24, 8:02AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced the submission of a request for ministerial dispensation to the Secretary of Parliament of South Africa to permit cannabis research in South Africa for medicinal purposes. Dr. Mario Oriani-Ambrosini, a South African legislator battling terminal cancer, recently introduced legislation to permit medical marijuana research and usage that has generated a groundswell of popular support and led to the formation of The Cancer Treatment Campaign.
Plandai Biotechnology, Inc. Announces Favorable Results for Human Clinical Trial
Marketwire - Thu Mar 20, 8:35AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced favorable results from a recent human clinical trial involving a topical preparation of its Phytofare(TM) Catechin Complex. The study, which was undertaken by Prof. Banie Boneschans, North West University in Potchefstroom, South Africa, one of the leading research universities on the continent, was a double-blind study that tested the anti-aging properties of Phytofare. Specifically, the trial tested surface parameters (scaling and roughness), skin hydration, and skin elasticity.
Plandai Biotechnology, Inc. Completes Stage 1 of Senteeko Phytofare Factory, Readies for Production
Marketwire - Tue Mar 18, 9:38AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced that it has completed and successfully tested Stage 1 of its state-of-the-art production facility on the Senteeko Tea Estate in South Africa. Video of the test is available on the company's website at www.plandaibiotech.com. Once fully commissioned, the factory will produce the company's proprietary Phytofare(TM) Catechin Complex, which is a highly bioavailable green tea extract that will be marketed to nutraceutical companies as an ingredient across a broad spectrum of health and wellness products.
Plandai Biotechnology Assumes Role in Legalizing Medical Marijuana in South Africa
Marketwire - Tue Mar 11, 5:01AM CDT
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it will assume a role in helping to craft legislation that is expected to result in the eventual legalization of marijuana for medical purposes in South Africa. Plandai has retained the law firm Werksmans Attorneys, (LEX Africa) Sandton, South Africa, which includes health law as one of its specialties, to draft and file the company's comments on a recently introduced legislative bill that if passed, would effectively legalize medical marijuana in that country and pave the way for expanded research.
Plandai Biotechnology buys remaining minority interest in Dunn Roman
M2 - Mon Mar 10, 8:02AM CDT
US-based plant extracts company Plandai Biotechnology (OTCQB
LPL) revealed on Friday the completion of the acquisition of another 18% ownership interest in Dunn Roman Holdings Africa (Pty). Plandai Biotechnology Announces Acquisition of Minority Holders' Interest in South African Subsidiaries
Marketwire - Fri Mar 07, 11:15AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has acquired an additional eighteen percent (18%) ownership interest in Dunn Roman Holdings Africa (Pty) Ltd, the South African holding and management company that operates the Senteeko Tea Estate and the Phytofare(TM) production facility. With this acquisition, Plandai now owns 100% of Dunn Roman.
Legalizing Medical Marijuana Gaining More Momentum in Mid-Term Election Year
Marketwire - Thu Mar 06, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) is one of a handful of publicly traded companies that are eagerly anticipating the legalization of medical marijuana nationwide. Currently the drug is legal medicinally in 20 states and Washington, D.C., but in this election year, that number is likely to grow. In each national election year, the frenzy begins again and with it, a growing momentum that has the U.S. drawing closer to a nationwide acceptance.
Plandai Biotechnology: A Natural Fit Into the Marijuana Industry
Marketwire - Mon Mar 03, 8:02AM CST
Plandai Biotechnology (OTCQB: PLPL) has a strong executive team in place, a well thought out business plan, and now it's time for the company to make its products the star. These products include Plandai's Phytofare(TM) botanical extracts such as its Green Tea Catechin Complex and the Limonoid Glycoside Complex, as well as a line of Diego Pellicer(R) medical cannabis products. It is the latter could make the company a leader in the marijuana industry.
Future of Plandai Biotechnology's Products in Good Hands With Former Microsoft Executive Heading Up Global Marketing
Marketwire - Tue Feb 25, 8:00AM CST
Today Plandai Biotechnology (OTCQB: PLPL) named former Microsoft executive Jamen Shively as the company's Vice President of Global Marketing. Shively has an extensive and impressive resume in the world of business, and the company is confident he can deliver Plandai's products on the world stage. According to Plandai, Shively will be responsible for building brand awareness and marketing strategy for all of the company's operations. Needless to say, they found just the right man for the future of their products.
Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing
Marketwire - Thu Feb 20, 8:03AM CST
Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Plandai, has been named as Vice President of Global Marketing.
Recent Marijuana News From Washington, D.C., Pivotal to Plandai Biotechnology's Success in the Industry
Marketwire - Wed Feb 19, 8:03AM CST
Plandai Biotechnology (OTCQB: PLPL) executives are certainly in favor of what 18 legislators are trying to accomplish with their letter to President Obama asking him to reclassify marijuana. They're likely equally as elated with news from the Administration last Friday that paves the way for legal banking between legitimate marijuana businesses and U.S. banks.
